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Abstract
Background: There is growing epidemiological evidence that short-term and long-term exposure to high levels
of air pollution may increase cardiovascular morbidity and mortality. In addition, epidemiological studies have
shown an association between air pollution exposure and respiratory health. To what extent the association
between cardiovascular mortality and air pollution is driven by the impact of air pollution on respiratory health
is unknown. The aim of this study was to investigate whether respiratory health at baseline contributes to the
effects of long-term exposure to high levels of air pollution on cardiovascular mortality in a cohort of elderly
women.
Method: We analyzed data from 4750 women, aged 55 at the baseline investigation in the years 1985–1994. 2593
of these women had their lung function tested by spirometry. Respiratory diseases and symptoms were asked by
questionnaire. Ambient air pollution exposure was assessed by the concentrations of NO2 and total suspended
particles at fixed monitoring sites and by the distance of residency to a major road. A mortality follow-up of these
women was conducted between 2001 and 2003. For the statistical analysis, Cox' regression was used.
Results: Women with impaired lung function or pre-existing respiratory diseases had a higher risk of dying from
cardiovascular causes. The impact of impaired lung function declined over time. The risk ratio (RR) of women
with forced expiratory volume in one second (FEV1) of less than 80% predicted to die from cardiovascular causes
was RR = 3.79 (95%CI: 1.64–8.74) at 5 years survival time and RR = 1.35 (95%CI: 0.66–2.77) at 12 years. The
association between air pollution levels and cardiovascular death rate was strong and statistically significant.
However, this association did only change marginally when including indicators of respiratory health into the
regression analysis. Furthermore, no interaction between air pollution and respiratory health on cardiovascular
mortality indicating a higher risk of those with impaired respiratory health could be detected.
Conclusion: Respiratory health is a predictor for cardiovascular mortality. In women followed about 15 years
after the baseline investigation at age 55 years long-term air pollution exposure and impaired respiratory health
were independently associated with increased cardiovascular mortality.
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Background
There is growing evidence that short and long-term expo-
sure to high levels of air pollution may increase cardiovas-
cular morbidity and mortality [1-5]. In addition,
epidemiological studies have shown an association
between increased levels of air pollution and exacerba-
tions of airways diseases [6] or impairments of lung func-
tion [7]. There is also support for a link between
respiratory health and cardiovascular mortality [8-10]. To
what extent the association between cardiovascular mor-
tality and air pollution is driven by the impact of air pol-
lution on respiratory health is unknown. It is
hypothesised that pulmonary inflammation induced
through harmful particles may cause the release of medi-
ators that increase blood coagulation [11,12]. Other stud-
ies have shown that increased blood coagulability or
viscosity is a risk factor for cardiovascular mortality [13].
However, other mechanisms not related to respiratory
health including systemic inflammation, accelerated
atherosclerosis and altered cardiac autonomic function
may also be responsible for the effect of particle exposure
on cardiovascular mortality [4].
Studies have shown that people with pre-existing respira-
tory disease have a higher risk of dying from cardiovascu-
lar causes due to short-time variations in air pollution
exposure [14-17]. Whether people with pre-existing respi-
ratory disease have a higher risk of dying from cardiovas-
cular disease after long-term air pollution exposure is not
clear. We have shown that high levels of air pollution were
associated with a reduction in lung function, impaired
respiratory health and chronic obstructive lung disease
[18] in women aged 55 years from the Ruhr Area in 1985–
1994. We also showed that these levels of air pollution
increased the risk of mortality in the same group of
women during a follow-up until 2002/2003 [19].
In this presented study, we investigated whether respira-
tory health at baseline contributes to the effects of long-
term exposure to high levels of air pollution on cardiovas-
cular mortality in this cohort of elderly women. Indicators
of respiratory health at baseline investigation were
chronic bronchitis and respiratory symptoms as well as
lung function measures. In compliance with the study
objective, the following questions were to be answered:
(1) Is impaired respiratory health a risk factor for cardio-
vascular mortality?
(2) Alongside long-term air pollution exposure, is
impaired respiratory health an independent risk factor for
cardiovascular mortality?
(3) Is there a difference in pollution induced cardiovascu-
lar mortality in people with and without impaired respi-
ratory health?
Method
Study population
The SALIA cohort (Study on the influence of Air pollution
on Lung function, Inflammation and Aging) was initiated
as part of the Environmental Health Surveys introduced
by the North Rhine Westphalia government in the mid
1980s, focusing on the effect of air pollution on respira-
tory health in women and children. Consecutive cross-
sectional studies were performed between 1985 and 1994
in the Ruhr area and two rural towns as reference areas.
The study population comprised 4874 women aged 55 at
the time of entering the study who were living in pre-
defined residential areas and willing to participate. In the
years specified, the study areas included Dortmund
(1985, 1990), Duisburg (1990), Essen (1990), Gelsen-
kirchen (1986, 1990) and Herne (1986) which represent
a range of high-polluted areas. The two rural towns,
Borken (1985, 1986, 1987, 1990, 1993, and 1994) and
Dülmen (1986) were chosen as reference areas. About
every second responder was invited to have her pulmo-
nary function tested, exceptions were Dortmund in 1990
where no lung function measurements were performed
and Borken in 1993/94 where all women were invited to
participate (N = 2593).
Follow-up study
The follow-up study was conducted by the Institute of Epi-
demiology (GSF Munich) between January 2002 and May
2003. All women were followed for the cause of specific
mortality. Causes of death were obtained from official
death certificates and were coded according to the Interna-
tional Classification of Diseases, Ninth Revision (ICD-9).
Mortality for all causes of death and cardiovascular
(ICD9-400-440) causes were recorded. The analysis was
restricted to 4750 from the 4874 women whose complete
information was available from the baseline investigation
and who could be followed-up in 2002–2003. Women
who moved during the follow-up period and who were
lost for the follow-up after moving were judged censored
at the time of movement. Otherwise, survival time was
censored at the time of follow-up or the time of death
from causes other than cardiovascular. The cause of death
is known for 399 women. The analysis presented focuses
on cardiovascular mortality.
Assessment of risk factors for respiratory health and 
cardiovascular mortality
Baseline co-morbidities and potential risk factors such as
smoking and the level of education were assessed by a
self-administered questionnaire. All returned question-
naires were checked by the investigating physician. WeRespiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
Page 3 of 11
(page number not for citation purposes)
grouped the women according to their reported smoking
habits: never smoker without environmental tobacco
smoke (ETS), passive-smoker (ETS at home and/or work
place), past smoker and current smoker (<15 pack years;
15–30 pack years and >= 30 pack years). Current smokers
with missing information about the numbers of cigarettes
smoked were assigned to smokers with > = 30 pack years.
These variables were used to control for confounding.
Their socio-economic status was determined by categoriz-
ing the women into three levels of education using the
highest school level completed by either the women or
her husband as low (< 10 years), medium (= 10 years) or
high (> 10 years).
Assessment of respiratory health by questionnaire
Identical standardized self-administered questions were
used during the entire screening period from 1985–1994.
The questionnaire included questions about impaired res-
piratory health. The following questions were used to
describe frequent cough with or without phlegm produc-
tion:
Do you usually cough in the morning, when you get up or
during the day?
If yes: Do you produce phlegm when you have this cough?
These questions are part of the classical definition of
chronic bronchitis [20]. We further asked:
Do you have a physician's diagnosis of chronic bronchi-
tis?
Assessment of respiratory health by pulmonary function
Spirometry was conducted using a Vica Test 4 spirometer
(Mijhardt, Rotterdam, The Netherlands). All measuring
instruments were calibrated prior to each session. At least
two acceptable spirograms were obtained from a mini-
mum of four forced expirations. A trained technician
identified the best single spirogram. All staff was specifi-
cally trained and the same measuring device was used
throughout the study. In our analysis, we used the forced
expiratory volume in one-second (FEV1) and the forced
vital capacity (FVC). Linear regression models were used
to predict the lung function parameter FEV1 and FVC
based on age, height, race and sex. We used the equations
which are recommended by the American Thoracic Soci-
ety [21]. The prediction equations for creating reference
values for these women were:
FEV1 
predicted  = 0.433-0.0036*age-
0.00019*age2+0.000115*height2
FVCpredicted  = -
0.356+0.0187*age*0.00038*age2*0.000148*height2
We defined impaired lung function by using FEV1 < 80%
and FVC < 80% of the predicted value of each parameter.
These cut-offs were also used in the re-analysis of the Har-
vard Six City Study [5]. To verify that these reference equa-
tions were suitable for our study collective, we applied
them to the women living in the rural areas (reference
areas). It turned out that the reference equations fitted
very well the lung function values of these women, i.e. 5%
of these women had lung function values below the 80%
cut-offs.
Assessment of air pollution exposure
We obtained the air pollution measurements data from 8
monitoring stations maintained by the State Environment
Agency of North-Rhine Westphalia. In each city concen-
trations of ambient air pollutants were measured at fixed
monitoring sites representing urban background levels.
The monitoring stations are located in an 8 km grid
throughout the women's residential areas. However, the
air pollution data from Borken and Dülmen are incom-
plete, because continuous measurements in this region
started in 1990. For the years proceeding 1990, the data
were imputed by using measurements (1981–2000) from
15 monitoring stations in the Ruhr area assuming similar
trends. Estimated 'average' differences were added to the
levels measured in 1990 to 1991 for the imputation of air
pollution concentrations in the years before 1990. The
estimated average differences were 1.02 µg/m3 per year for
NO2 and 1.36 µg/m3per year for PM10. More details can be
found elsewhere [19].
To estimate the long-term air pollution exposure we used
five-year means of measurements done before the investi-
gation. The concentrations of nitrogen dioxide (NO2)
were measured half-hourly by means of chemo-lumines-
cence. Total suspended particles (TSP) were gathered with
a low volume sampler (air flow: 1 m3/h) and measured
using beta-ray absorption. For reasons of comparability
with studies based on PM10 measurements (particulate
matter with aerodynamic diameters less than 10 µm), we
estimated the corresponding PM10 values by multiplying
the TSP measurements with a conversion factor of 0.71.
Details for justification of this conversion factor can be
found elsewhere [19]. We further used geographic infor-
mation system (GIS) software Arc GIS 9.0 (ESRI Redlands,
Cato) to calculate the distance of the residential address to
the nearest major road with more than 10,000 cars/day. A
distance of 50 m to the nearest major road was used as cut-
off to reflect small-scale spatial variations in traffic related
exposure. Traffic counts were provided by the North
Rhine Westphalia State Environment Agency (LUA NRW).
Statistical methods
Cox' proportional hazard regression model was used to
analyze the association between cardiovascular mortality,Respiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
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air pollution exposure and respiratory health. Following
the study questions, three analysis steps were done:
First, we investigated whether cardiovascular death was
associated with impaired respiratory health. The assump-
tion of proportional hazard was tested by introducing a
time-dependent covariate into the Cox' model [22]. This
new variable was defined as the product of the logarithm
of survival time with the binary variable characterising
impaired respiratory health. The proportionality assump-
tion was rejected when the regression coefficient of this
covariate was significantly (p < 0.1) different from the null
value. We presented relative risks of cardiovascular death
due to respiratory health impairment at two survival times
(5 years (60 month) and 12 years (144 month)) which
correspond roughly to the 25th and 75th percentile of the
survival time distribution of those who died in the study
group.
Second, the risk ratios of cardiovascular mortality for each
air pollution indicator were estimated adjusted for poten-
tial confounders (model (a)). Educational level and
smoking behaviour had already been identified as rele-
vant confounders in our previous paper [19]. Then, respi-
ratory health indicators were additionally considered in
the Cox' regression analysis (model (b)). If the assump-
tion of hazard proportionality for the respiratory health
strata was not met (result of step one) then a stratified
analysis was done and, if no interaction between respira-
tory health and air pollution exposure had to be taken
into account (if otherwise see step three), common risk
ratio estimates of the strata were given. No or negligible
differences between the estimated risk ratios for air pollu-
tion exposure between model (a) and model (b) indicate
that respiratory health is an independent risk factor for
cardiovascular mortality alongside air pollution exposure.
Third, it was determined whether the relative risks for air
pollution associated cardiovascular mortality were differ-
ent in strata defined by respiratory health. Because of the
small power of interaction tests a p-value of 0.3 or less was
chosen as indication for interaction. If the p-value was
less, then no combined estimates but estimates for both
strata are given separately.
Risk ratio estimates of continuous exposure measures
refer to unit steps as chosen in [18,19], i.e. 16 µg/m3 and
7 µg/m3 for NO2 and PM10, respectively.
Survival times in subgroups defined by respiratory health
indicators were graphically depicted by Kaplan-Meier
curves with 95 percent confidence limits.
All analyses were conducted with the statistical software
SAS. For Cox' regression analysis, we used the procedure
PHREG of SAS version 9.1 for windows (SAS Institute
Cary, NC).
Results
Description of the study participants
In total, 4750 women were in the study, and a percentage
of 54.5% underwent lung function testing. Distribution
characteristics of the whole study group and, separately, of
the sub-group with lung function measures are summa-
rised with respect to respiratory health, mortality and
other socio-demographic indicators in table 1. Due to the
study design the women who had their lung function
tested lived to a larger extent in rural areas and related to
that they were to some extent healthier and smoked less
than those in the whole study group. Again, because of the
design, air pollution exposure in the sub-group with
spirometry was slightly lower than in the whole study
group (table 2).
Respiratory health and cardiovascular mortality
In table 3, crude risk ratios (RRc) demonstrate that cardio-
vascular death was associated with impaired respiratory
health and unfavourable lung function values. The associ-
ation between cardiovascular mortality and impaired res-
piratory health defined by diagnosis and symptoms
demonstrated a different time pattern than that defined
by lung function measurements. The association of the
diagnosis of chronic bronchitis with cardiovascular mor-
tality did not change over time: Women with the diagno-
sis of chronic bronchitis had an increased risk ratio of
dying from cardiovascular causes at 60 months survival
time (RRc = 1.53; 95% CI: 0.83–2.79) and at 144 months
survival time (RRc = 1.65; 95% CI: 0.93–2.95). Similar
results were found for frequent cough with phlegm pro-
duction. The impact of impaired lung function at age 55
years on cardiovascular mortality however declined over
time. Figure 1 and 2 show the survival curves of women
with and without impaired FEV1 and FVC. The propor-
tionality assumption is not valid. Interaction with survival
time was significant for both lung function indicators
(table 3). The risk of women with impaired lung function
at age 55 years to die from cardiovascular causes at the age
of 60 years, was 3.8 to 5.0 times higher than the risk of
women without pathological findings of the lung func-
tion. The risk ratio at the age of 67 years declined near the
null value (table 3).
Respiratory health indicators as additional covariates for 
the association between air pollution exposure and 
cardiovascular mortality
In a previous paper we could provide evidence that an
increase of exposure to PM10 was strongly associated with
a reduction of lung function (FEV1: 5.1% (95% CI 2.5%–
7.7%), FVC: 3.7% (95% CI 1.8%–5.5%)) as well as with
increased frequency of respiratory symptoms [18]. In aRespiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
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Table 2: Distribution of women depending on their ambient air pollution exposure (5 year mean values prior to baseline investigation) 
and traffic exposure indicated as percentiles
Mean/Percentage P0 P25 P50 P75 P100
Whole study group (N = 4750)
NO2 [µg/m3]3 9 2 2 2 5 4 6 4 9 5 5
PM10 [µg/m3]4 8 3 9 4 3 4 7 5 3 5 6
<50 m distance to major road (>10,000 cars/day) 8.5 % -- -- -- -- --
Study group with spirometry (N = 2580)
NO2 [µg/m3]3 6 2 2 2 4 2 7 5 0 5 3
PM10 [µg/m3]4 7 3 9 4 3 4 7 5 2 5 4
<50 m distance to major road (>10,000 cars/day) 7.6 % -- -- -- -- --
Abbreviations:
Px: xth percentile; NO2: Nitrogen dioxide; PM10: Particulate matter with aerodynamic diameter of ≤ 10 µm, calculated as PM10 = 0.71*TSP; TSP: 
Total suspended particles
Table 1: Characteristics of impaired respiratory health, mortality and socio-demographics of a cohort of women aged 55 years at 
baseline investigation
Whole study group N = 4750 Study group with spirometry N = 2580
n/N % n/N %
FEV1 <80% of predicted value -- -- 409/2577 15.9
FVC <80% of predicted value -- -- 526/2571 20.5
Chronic Bronchitis by physician diagnose 442/4642 9.5 211/2525 8.4
Frequent cough with phlegm production 518/4700 11.0 266/2554 10.4
Frequent cough 1063/4724 22.5 560/2568 21.8
All cause death 399/4750 8.4 183/2580 7.1
Cardiovascular death 127/4750 2.7 53/2580 2.1
Never smoker without ETS 1779/4750 37.5 1191/2577 46.2
Never smoker with ETS 1494/4750 31.5 829/2577 32.2
Ex-smoker 377/4750 7.9 201/2577 7.8
Current smoker with < 15 pack years 270/4750 5.7 136/2577 5.3
Current smoker with 15–30 pack years 284/4755 6.0 137/2577 5.3
Current smoker > 30 pack years 224/4755 4.7 83/2577 3.2
Smoking behaviour unknown 322/4750 6.8 143/2577 5.5
Living in rural area 1681/4750 35.4 1315/2580 51.0
Less then 10 y school 1400/4695 29.8 685/2574 26.6
At least 10 y school 2243/4695 47.8 1253/2574 48.7
More then 10 y school 1052/4695 22.4 636/2574 24.7
N Mean/SD N Mean/SD
Age [years] 4748 54.5/0.6 2576 54.5/0.7
Abbreviations:
FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity; SD: Standard deviationRespiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
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further paper we have shown [19], that the association
between air pollution levels and cardiopulmonary death
rate was strong and statistically significant. This was also
true for cardiovascular death, which we focused on in this
paper (table 4). Table 4 shows the results of the Cox'
regression analysis for the impact of air pollution expo-
sure on cardiovascular mortality adjusted for confounders
(model (a)) and additionally for respiratory disease or
symptoms (model (b)). The risk ratios for the association
between air pollution and cardiovascular mortality dif-
fered only marginally (<10%) between model (a) and
model (b). We also tested all interactions between respira-
tory diagnosis and symptoms and air pollution on cardi-
ovascular mortality. All p-values were above 0.3.
Therefore no separate estimates in strata defined by respi-
ratory health are given.
For both lung function indicators the assumption of haz-
ard proportionality over time was not valid. We therefore
applied stratified Cox' regression analysis for model (b).
The results are presented in table 5. In this sub-group of
women with lung function measurements, the associa-
tions between traffic related pollution (NO2 and small
distance to mayor road) and cardiovascular death were
particularly strong. This again might be due to the study
design which led to more pronounced contrasts in traffic
related pollution. The associations between traffic related
air pollution exposure (distance to major road and ambi-
ent NO2) and cardiovascular mortality were modified by
impaired lung function. However, this modification was
contrary to the meaningful expectation that impaired lung
function would increase the risk ratio of air pollution
exposure.
Kaplan-Meier survival curves with 95 percent confidence limits of cardiovascular mortality for women aged 55 years at baseline  investigation with FEV1 < 80% predicted and FEV1 ≥ 80% predicted; dots indicating censored events Figure 1
Kaplan-Meier survival curves with 95 percent confidence limits of cardiovascular mortality for women aged 55 years at baseline 
investigation with FEV1 < 80% predicted and FEV1 ≥ 80% predicted; dots indicating censored events. Abbreviations: FEV1: Forced 
expiratory volume in 1 second.Respiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
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Table 3: Crude risk ratios (RRc) and 95% confidence interval (95% CI) of cardiovascular mortality for impaired respiratory health and 
lung function indicators at 5 and at 12 years of survival time and p-value for interaction with baseline, results of Cox' regression 
analysis.
Respiratory symptoms and lung function RRc, 95% CI at 5 years RRc, 95% CI at 12 years p-value for interaction with baseline
Chronic Bronchitis by physician diagnose 1.53
0.83–2.79
1.65
0.93–2.95
0.7986
Frequent cough with phlegm production 1.34
0.71–2.51
1.65
0.94–2.89
0.5377
Frequent cough 1.17
0.73–1.89
1.21
0.76–1.93
0.9006
FEV1 < 80% of predicted value 3.79
1.64–8.74
1.35
0.66–2.77
0.0303
FVC <80% of predicted value 5.03
2.10–12.02
1.89
1.01–3.57
0.0445
Abbreviations:
FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity;
Kaplan-Meier survival curves with 95 percent confidence limits of cardiovascular mortality for women aged 55 years at baseline  investigation with FVC < 80% predicted and FVC ≥ 80% predicted; dots indicating censored events Figure 2
Kaplan-Meier survival curves with 95 percent confidence limits of cardiovascular mortality for women aged 55 years at baseline 
investigation with FVC < 80% predicted and FVC ≥ 80% predicted; dots indicating censored events. Abbreviations: FVC: Forced 
vital capacityRespiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
Page 8 of 11
(page number not for citation purposes)
Table 5: The influence of lung function indicators, measured at baseline investigation, on the association between air pollution 
exposure (traffic, NO2, PM10) and cardiovascular mortality in a cohort of women aged 55 years at baseline investigation; results of a 
Cox' regression analysis.
<50 m distance to major road NO2[16 µg/m2] (five-year mean) 1 PM10[7 µg/m2] (five-year mean) 1
RR 95%-CI p-value RR 95%-CI p-value RR 95%-CI p-value
n/N 52/2478 42/2328 42/2328
Model (a), adjusted for potential 
confounders2
2.33 1.09–4.95 0.0288 1.91 1.22–2.98 0.0048 1.26 0.75–2.14 0.3882
Model (b), additionally estimated in strata defined by or adjusted3 for:
FEV1 < 80% 1.12 0.52–2.41 0.7683
2.274 1.06–4.85 0.0339 1.144 0.67–1.95 0.6352
FEV1 ≥ 80% 2.23 1.27–3.89 0.0049
FVC < 80% 1.21 0.28–5.25 0.7951 1.13 0.57–2.22 0.7329
1.134 0.66–1.93 0.6621
FVC ≥ 80% 3.20 1.30–7.85 0.0112 2.38 1.30–4.34 0.0047
1 Analyses on long term exposure to air pollution were made on subjects who were living longer than five years under their current address.
2 Educational level and smoking
3 if p-value of interaction between air pollution exposure and lung function indicator was greater 0.3
4 Common estimation for both strata because of no interaction between lung function indicator and air pollution exposure
Abbreviations:
RR: Risk ratio; CI: Confidence interval; n/N: number of dead and sample size; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital 
capacity
Model (a)/(b): see text
Table 4: The influence of respiratory health indicators (diagnoses and symptoms), assessed at baseline investigation, on the association 
between air pollution exposure (traffic, NO2, PM10) and cardiovascular mortality in a cohort of women aged 55 years at baseline 
investigation; results of a Cox' regression analysis.
<50 m distance to major road NO2[16µg/m3] (five-year mean) 1 PM10[7µg/m3] (five-year mean)1
RR 95%-CI p-value RR 95%-CI p-value RR 95%-CI p-value
n/N 120/4457 97/4198 97/4198
Model (a), adjusted for potential 
confounders3
1.67 0.98–2.83 0.0573 1.72 1.24–2.39 0.0011 1.64 1.15–2.33 0.0056
Model (b), additionally adjusted for
Chronic Bronchitis by physician 
diagnose
1.63 0.96–2.76 0.0693 1.69 1.22–2.35 0.0017 1.62 1.14–2.30 0.0073
Frequent cough with phlegm 
production
1.71 1.01–2.88 0.0478 1.70 1.22–2.36 0.0015 1.62 1.14–2.31 0.0071
Frequent cough 1.71 1.01–2.88 0.0469 1.71 1.23–2.37 0.0013 1.63 1.15–2.32 0.0067
1 Analyses on long term exposure to air pollution were made on subjects who were living longer than five years under their current address.
2 Current smoking at the time of entering the study, no further adjustment for exposure to tobacco smoking
3 Educational level and smoking
Abbreviations:
RR: Risk ratio; CI: Confidence interval; n/N: number of dead and sample size
Model (a)/(b): see textRespiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
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Discussion
Our study demonstrates that impaired respiratory health
at the age of 55 is a risk factor for cardiovascular mortality.
Women with impaired lung function had a higher cardio-
vascular mortality risk especially in the first years after the
investigation. The impact of air pollution however was
even less strong in these women than in those with nor-
mal lung function. We could not find an indication that
women with impaired respiratory health would have an
increased risk of suffering cardiovascular death associated
with increased long-term exposure to air pollution. There-
fore, long-term air pollution exposure and impaired respi-
ratory health are independently associated with
cardiovascular mortality.
Our findings in regards to the positive association
between respiratory impairment and cardiovascular mor-
tality are consistent with other published studies [23,8-
10]. The studies from Schunemann et al. and Sin et al. also
showed that decreased pulmonary function is a risk factor
for cardiovascular mortality [8,10]. Yet, these studies did
not investigate the relation between impaired respiratory
health and air pollution-associated cardiovascular mortal-
ity. In contrast to these studies we found that the risk asso-
ciated with impaired lung function declined over time.
There are several hypotheses about the general pathways
of cardiovascular effects due to increased levels of air pol-
lution [24,25]. One hypothesised that a biological path-
way for cardiovascular mortality associated with long-
term exposure to air pollution is pollution-induced lung
damage. It suggests that in individuals who are suscepti-
ble, exposure to air pollution especially to ultrafine parti-
cles can induce alveolar inflammation, which
subsequently result in respiratory illness and then in car-
diovascular death [11,12]. The second hypothesis indi-
cates that lung inflammation induced by air pollution not
only leads to lung diseases, but independently can also
cause vascular and heart diseases [25,26]. Alveolar macro-
phages and lung epithelial cells process inhaled particles
or other air pollutants, this pro-inflammatory mediators
not only promote a local inflammatory response in the
lungs, but can also translocate into the circulation and
induce a systemic inflammatory response [27]. Conse-
quently, the possible biological pathway for this associa-
tion is systemic inflammation and the progression of
atherosclerosis [28]. Further, air pollution can lead to
altered cardiac function due to a change in heart rate and
blood pressure and finally lead to death [29-32].
The results of our study are more consistent with the sec-
ond hypothesis. In fact, in our cohort study we could
show that air pollution and impaired respiratory health
are independently associated with cardiovascular death.
Indeed women with already impaired lung function had a
higher cardiovascular mortality risk especially in the first
years after the investigation compared to those with nor-
mal lung function. But, increased levels of air pollution
did not influence the mortality of these women. On the
contrary, the relative risk of cardiovascular mortality asso-
ciated with air pollution appeared to be higher in women
without impaired lung function. In some women possi-
bly, impaired lung function might be a sign for a still
unknown but manifest cardiovascular disease which sub-
sequently leads to early death not related to air pollution.
However because of the relative small subgroups we chose
a p-value of 0.3 to indicate an interaction. Therefore, the
evidence for the variation in risk between the sub-groups
is still not strong.
This observed result is in accordance with findings from
the re-analysis of the Harvard Six City Study [4,5]. In their
study, Krewski et al. reported about the risk of death asso-
ciated with exposure to fine particles in different sub-
groups among them those defined by lung function. In
their study subjects with compromised lung function had
a slightly greater risk of death. However, none of these
interactions achieved statistical significance. The results of
this re-analysis did not provide evidence of variation in
risks among population sub-groups [5].
In a previous time series study, DeLeon et al. [14]
observed that individuals with contributing respiratory
conditions whose primary cause of death was circulatory
were more affected by elevated levels of air pollution This
role of respiratory disease in air pollution related cardio-
vascular mortality could not be confirmed in our study.
There are two major differences to our study. First, the
DeLeon-study focused primarily on daily mortality counts
and the listing of the contributing respiratory causes on
the death certificates. However, time-series studies can
only investigate associations with the most recent expo-
sure compared to cohort studies, which are able to show
acute and chronic effects of air pollution on diseases and
mortality. Second, DeLeon et al. demonstrated that the
effect was only visible in older individuals (aged 75 and
older) with underlying respiratory diseases. Older individ-
uals were more susceptible to adverse effects of air pollu-
tion. The women followed up in our study were at most
73 years old. Therefore, the lack of effect in our study
might be due to the younger age range.
Our study has certain limitations. The respiratory symp-
toms and the chronic bronchitis were self-reported, which
might lead to some reporting bias. Furthermore, the
women received only one lung function measurement,
and we relied on cause-of-death data from death certifi-
cates which has the potential of bias for specific cause of
death. As in most studies dealing with influences of cov-
ariates on survival of population groups, we chose Cox'Respiratory Research 2007, 8:20 http://respiratory-research.com/content/8/1/20
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Regression for analysis. This is basically a multiplicative
approach. Therefore, our result of an independent associ-
ation of air pollution and respiratory health on cardio vas-
cular mortality can only be interpreted in this
multiplicative context. The number of women with
reduced lung function, respiratory diseases and cardiovas-
cular mortality was low with respect to the statistical
power of the study and was further reduced by stratifica-
tion. Another limitation is the incompleteness of air pol-
lution measurements. Values for the reference areas
Borken and Dülmen before 1990 were imputed assuming
similar trends as in the high-polluted areas. The estima-
tion of ambient air PM10 concentrations by using TSP
measurements may add another limitation to the study
and may result into a bias of our risk ratio estimates.
Indeed, assuming a smaller conversion factor for the rural
area, for instance 0.65, which means greater fraction of
coarse particles in TSP compared to the urban areas, the
inconsistency of the results between table 4 and table 5
diminished. In tables 4 and 5, the risk ratios for PM10
using model (a) increased and showed similar results to
the risk ratio for the influence of traffic and NO2 (data not
shown). However, this modification of the TSP/PM10 con-
version factor did not influence our main results, namely,
the association between lung function and respiratory
health indicators and cardiovascular mortality.
The strength of our analysis is the long follow-up of our
cohort with multiple exposure assessments of air pollu-
tion levels and different respiratory health assessments
(respiratory symptoms and lung function measurements).
In conclusion, the results from our analysis show that
impaired respiratory health as measured by diagnoses,
symptoms and lung function is related to an increased
subsequent cardiovascular mortality. Women with
impaired lung function had a higher cardiovascular mor-
tality risk, especially in the first years after the investiga-
tion. We observed some indications that the impact of air
pollution however was weaker in these women than in
those with normal lung function. We therefore concluded
that long-term exposure to high levels of air pollution
affects respiratory health and cardiovascular death inde-
pendently in a group of middle aged women. However,
due to the short follow-up period of these women, we
might have underestimated the long-term air pollution
effects on less pronounced respiratory damage. A further
follow-up study of these women is needed to provide
more information about cardiovascular mortality in this
group when they become older.
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